Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial

2014 ◽  
Vol 15 (12) ◽  
pp. 1369-1378 ◽  
Author(s):  
Suresh S Ramalingam ◽  
Pasi A Jänne ◽  
Tony Mok ◽  
Kenneth O'Byrne ◽  
Michael J Boyer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Stage ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Double Blind ◽  
Previously Treated

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

2014 ◽  
Vol 15 (1) ◽  
pp. 59-68 ◽  
Author(s):  
Charles Butts ◽  
Mark A Socinski ◽  
Paul L Mitchell ◽  
Nick Thatcher ◽  
Libor Havel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Double Blind

scholarly journals Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

2018 ◽  
Vol 19 (4) ◽  
pp. e405-e415 ◽  
Author(s):  
Toyoaki Hida ◽  
Reiko Kaji ◽  
Miyako Satouchi ◽  
Norihiko Ikeda ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document